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Purpose.The purpose of this study was to compare the analgesic properties of levobupivacaine with or without fentanyl for patient-
controlled epidural analgesia afterCesarean section in a randomized, double-blinded study.Methods.WeenrolledAmerican Society
of Anesthesiologists class I/II, full-term pregnant women at National Taiwan University Hospital who received patient-controlled
epidural analgesia after Cesarean section between 2009 and 2010. Eighty women were randomly assigned into two groups. In
group A, the 40 subjects received drug solutions made of 0.6mg/ml levobupivacaine plus 2mcg/ml fentanyl, and in group B the
40 subjects received 1mg/ml levobupivacaine. Maintenance was self-administered boluses and a continuous background infusion.
Results.There were no significant differences in the resting and dynamic pain scales and total volume of drug used between the two
groups. Patient satisfaction was good in both groups.Conclusion.Our study showed that pure epidural levobupivacaine can provide
comparative analgesic properties to the levobupivacaine-fentanyl combination after Cesarean section. Pure levobupivacaine may
serve as an alternative pain control regimen to avoid opioid-related adverse events in parturients.
1. Introduction
Good analgesia after Cesarean section (C/S) is important
for maternal-child bonding, early ambulation, and discharge.
Several studies revealed that the analgesic efficacy of neu-
raxial morphine was superior to that of intravenous or
intramuscular opioids [1, 2]. However, adverse responses to
neuraxial morphine, such as nausea or vomiting, pruritus,
and dizziness, were reported to be dose related in some
studies and not to be dose related in others [3–5]. One
study showed that epidural local anesthesia with opioids
induced better pain relief and caused less nausea/vomiting
than intrathecal morphine [6].
Pure local anesthetics are not widely used for routine
postoperative epidural analgesia because of the significant
rate of insufficient pain relief and unacceptable incidence of
motor blockade [7, 8]. However, we have been using pure
epidural ropivacaine after C/S, and it offered comparable
analgesic efficacy to epidural morphine without delaying the
time of first ambulation [9]. Similarly, levobupivacaine has
similar advantages to ropivacaine, and it has less toxicity
to the central nervous system and heart and fewer motor-
blocking properties than bupivacaine [10]. Based on these
considerations, we posited that pure epidural levobupiva-
caine may also provide good analgesia after C/S.
We conducted a pilot study to determine the lowest
effective concentrations of pure levobupivacaine and lev-
obupivacaine with fentanyl to provide analgesia after C/S.
The parturients were split into two groups (1 and 2). The
first parturient in each group received 1.2mg/mL levobupi-
vacaine, and the parturients in group 1 received an additional
2mcg/mL of fentanyl. This concentration of levobupivacaine
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was chosen because it was between the motor blocking
minimum local anesthetic concentration andminimum local
analgesic concentration of levobupivacaine based on Lacassie
et al. [11] andRobinson et al.’s [12] studies, respectively. A basal
infusion of 3mL/h and a bolus of 2mL were selected. We
reduced the levobupivacaine concentration by 0.2mg/mL for
the next parturient if the previous one had lower limb numb-
ness on the 12th hour and stopped reducing the concentration
until a parturient who had a pain score > 4 (VAS; 0 = no pain
at all, 10 = the worst imaginable pain) on the 12th hour or vice
versa. The results of our pilot study indicated that 0.6mg/mL
levobupivacaine plus 2mcg/mL fentanyl and 1mg/mL of pure
levobupivacaine were the lowest concentrations of the drugs
required to provide effective analgesia. In this pilot study, the
parturients who received these two different regimens had
similar pain scores and total regimen amounts.Therefore, we
hypothesized that these two regimens were “equianalgesic,”
and we designed a randomized, prospective, double-blinded
study to compare the analgesic properties of the two regi-
mens.
2. Materials and Methods
This research was conducted at the National Taiwan Univer-
sity Hospital, Taipei, Taiwan, from July 2009 to December
2010. After acquiring institutional review board approval and
written informed consents, we enrolled American Society of
Anesthesiologists (ASA) class I/II, full-term, healthy preg-
nant women who received regional anesthesia for a sched-
uled C/S and submitted permission for patient-controlled
epidural analgesia (PCEA) in the study. Exclusion criteria
were concomitant or previous intra-abdominal surgeries
other than C/S, histories of intra-abdominal infection, and
congenital intrauterine anomalies (i.e., septate or double
uterus). All recruited women were randomly assigned to one
of two groups by computer-generated randomization: group
A received 0.6mg/mL levobupivacaine plus 2mcg/mL fen-
tanyl and group B received 1mg/mL levobupivacaine. In the
operation room, one of two research members who prepared
the study regimen inserted an epidural needle through the
3rd or 4th lumbar spinal space, turned the bevel rostrally, and
threaded a catheter 5 cm into the epidural space. Anesthesia
was performed with 10mg of 0.5% hyperbaric intrathecal
bupivacaine and a supplement of 2% epidural lidocaine
(60mg every 5 minutes) until a T6 sensory blockade was
achieved.
The 48-hour study period began in the postanesthesia
care unit (PACU) with the following PCEA settings: 2mL for
bolus, 3mL/h for continuous infusion, a 20-minute lock out
interval, and a 4-hour limit of 30mL. Parturients received
a first dose of 20mg intravenous tenoxicam in PACU and
subsequent doses every 6 hours for 48 hours. The primary
outcome was the dynamic and resting VAS scores during
ambulation and bed rest (on the 6th, 12th, 18th, and 24th
hours); the secondary outcomes were (1) the total dose of
the regimen administered on the 48th hour, (2) parturient
satisfaction with the quality of pain management on the 48th
hour (2 = very satisfied, 1 = satisfied, 0 = fair,−1 = dissatisfied,
Table 1: Bromage score.
Score Description
4 Ability to raise extended legs
3 Inability to raise extended legs and decreased kneeflexion, but full extension of feet and ankles present
2 Inability to raise legs or flex knees, but flexion of anklespresent
1 Inability to raise legs, flex knees or ankles, or move toes
and −2 = very dissatisfied), and (3) parturient self-reported
severity (1 = mild, 2 = moderate, and 3 = severe) of adverse
events (i.e., lower limb numbness, nausea or vomiting,
dizziness, pruritus, sleepiness, and urinary retention) at the
12th hour. Motor blockade was additionally rated with the
Bromage score [13]. Table 1 shows the Bromage score. An
acute pain service team, whose members were blinded to the
regimens, recorded the primary and secondary outcome data.
Parturients who used the PCEA for less than 48 hours were
exempt from total volume of drug used.
2.1. Statistical Analysis. The number of parturients included
in the study was based on a previous study by Dernedde et al.
[14] and on a power calculation assuming a 20% difference
with 𝑎 = 0.05 and 𝑏 = 0.20. Results were expressed as
the mean (± standard deviation) for quantitative variables.
Comparison of mean values between groups was performed
using the Student’s 𝑡-test for the VAS measurements, total
drug consumptions, and adverse events. Repeated measures
analysis of variance (ANOVA) was used to analyze the VAS
scores within groups. Proportions were compared by the
classical chi-squared test for ASA classifications, previous
C/S, Bromage scores, and parturient satisfaction. Resultswere
considered to be significant at the 5% critical level (𝑃 < 0.05).
3. Results
Figure 1 shows the flowchart of the parturients enrolled
in the study. Eighty-three women were enrolled. Three
were excluded because of concomitant surgeries (i.e., two
myomectomies and one adnexectomy). A total of 80 women
were included and randomly divided into two groups (A
and B), with 40 women in each group. Table 2 shows the
baseline parturient characteristics. Two women in group B
were exempted from the total volume of drug used mea-
surements because of early discontinuation due to catheter
dislodgement or intolerable pruritus associated with 3M
paper adhesive tape.
For the primary outcomes, the average resting and
dynamic VAS scores showed no differences on the 6th, 18th,
and 24th hours between the two groups (Figure 2).There was
no difference in total volume of drug used: 185.6 (±25.4)mL
in groupA versus 184.6 (±29.7)mL in groupB (𝑃 = 0.88).The
overall satisfaction responses were as follows: 1 parturient had
a score of 0, 38 parturients had a score of 1, and 1 parturient
had a score of 2 in each group (Figure 4).
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Figure 1: Diagram showing the flow of the patients enrolled in the study.
Table 2: Baseline parturient characteristics. Values are mean (SD) [95% confidence interval] or number (proportion).
Group A (𝑛 = 40) Group B (𝑛 = 40) 𝑃
Age; years 34.1 (3.57) [32.99–35.21] 34.8 (3.4) [33.75–35.85] 0.72
Height; cm 159.8 (4.76) [158.32–161.28] 160.7 (4.7) [159.24–162.16] 0.99
Weight; kg 65.7 (9.78) [62.67–68.73] 69.1 (9.9) [66.03–72.17] 0.84
BMI; kg⋅m2 26.0 (3.2) [25.01–26.99] 26.7 (3.3) [25.68–27.72] 0.36
Gestational age; week 38.5 (1.0) [38.19–38.81] 38.6 (0.8) [38.35–38.85] 0.87
ASA class I 17 (42.5%) 16 (40%) 0.82
ASA class II 23 (57.5%) 24 (60%)
Previous Caesarean section 14 (35%) 19 (47.5%) 0.26
BMI: body mass index; ASA: American Society of Anesthesiologists.
For the secondary outcomes, all subjects reported the
severity of adverse events to be mild (score = 1). For group
A versus group B, the incidence of nausea or vomiting was
20% versus 17.5% (𝑃 = 0.41), the incidence of dizziness was
32.5% versus 15% (𝑃 = 0.019), the incidence of pruritus was
27.5% versus 0% (𝑃 = 0.0001), the incidence of lower limb
numbness was 37.5% versus 67.5% (𝑃 = 0.0045), and the
incidence of urinary retention was 0% versus 5% (𝑃 = 0.075).
The Bromage score was 4 in 37 women in group A versus 34
women in group B, and the score was 3 in three women in
group A versus six women in group B (𝑃 = 0.29 between two
groups). Figure 3 shows the incidence of adverse events in the
two groups.
There were no significant differences between parturients
with previous C/S (14 in group A and 19 in group B) and
parturients without previous C/S in each group in terms of
the average resting and dynamic VAS scores and total drug
consumptions.
4. Discussion
The results of our study showed that pure levobupivacaine
produced comparable analgesic properties to the levobupi-
vacaine-fentanyl combination for post-C/S pain control.
There were insignificantly higher resting and dynamic VAS
scores on the 12th hour than on the 6th hour, which could
be related to an incomplete regression of spinal anesthesia
on the 6th hour and routine eight-hour bed rest after spinal
anesthesia.
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Figure 2: Average resting and dynamic pain scores on the 6th, 12th,
18th, and 24th hours. VAS: visual analog scale; ∗𝑃 = 0.03.











Figure 3: Incidence of adverse events in group A (gray column)
and group B (black column). All events were mild in severity; ∗𝑃 =
0.019, ∗∗𝑃 = 0.0001, and ∗∗∗𝑃 = 0.0045.
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Figure 4: Parturient satisfactory score.
In accordance with expectations, parturients who
received fentanyl suffered more from opioid-related adverse
reactions, such as dizziness and pruritus, whereas those
who received pure levobupivacaine experienced more local
anesthetic-induced lower limb numbness. In our study, these
adverse events were all mild and tolerable, and no woman
was dissatisfied with the analgesic effect. Mild lower limb
numbness that did not affect ambulation occurred in 67.5%
of parturients in group B and in 37.5% in group A. This
numbness might result from an epidural placed in a lower
space than the correlated dermatome of the surgical wound
(T12–L1). Visser et al. concluded that the intervertebral
level is a statistically significant factor in the distribution of
sensory blockade, and a low thoracic insertion was shown
to cause less motor blockade than a high lumbar epidural
approach [15]. Moreover, eight women (three in group A and
five in group B) with lower limb numbness had symptom
relief after withdrawing the catheter by 1 to 3 cm, which may
have alleviated nerve root irritation [16].
As for the PCEA setting, there have been no published
data on post-C/S pain control. Some studies revealed that
using a low concentration and a high volume of local
anesthetic provided adequate analgesia and reduced motor
blockade [14, 17–21]. Some researchers concluded that PCEA
with a continuous background infusion had better analgesic
properties than demand-only PCEA [22–24]. In our study, we
used a low concentration of levobupivacaine with a baseline
infusion of 3mL/h and a bolus of 2mL, which was less than
the concentration used in previous studies [7, 25, 26]. The
satisfactory analgesia afforded in our setting might be due to
the average shorter stature of the subjects in this study [27] or
be due to less analgesic anticipation among Asian women.
There are several limitations in our study. First, it is
difficult to define an “equianalgesic” concentration of two
different regimens. Second, a parturient might not acquire
adequate analgesia for uterine contractions despite several
boluses, and, as a consequence, the total volume of drug used
might increase while the satisfaction decreases. Third, this
study did not analyze differences in the duration of C/S and
total intraoperative local anesthetic use between groups and
the potential impact of these factors on postoperative baseline
pain levels. A further limitation is that we did not study
the analgesic properties of 1.0mg/mL levobupivacaine plus
2mcg/mL fentanyl and pure 0.6mg/mL levobupivacaine,
since the two regimens had already been ruled out in our
pilot study for the adverse effect (lower limb numbness) and
insufficient analgesia, respectively.
5. Conclusions
From our study, we conclude that in equivalent doses PCEA
levobupivacaine with fentanyl has more dizziness and pruri-
tus and less paraesthesia than PCEA levobupivacaine alone.
Pure levobupivacaine could be an alternative regimen for
parturients who have had previous negative experiences with
or are concerned about opioid-related adverse events.
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